Literature DB >> 27385807

Stability of Cefepime in pH-Neutral Peritoneal Dialysis Solutions Packaged in Dual-Compartment Bags.

Farzana Yousaf1, Syed T R Zaidi1, Troy Wanandy2, Matthew D Jose3, Rahul P Patel4.   

Abstract

Intraperitoneal cefepime is used for the treatment of peritoneal dialysis (PD)-associated peritonitis caused by gram-negative bacteria. The current study investigated the stability of cefepime in a pH-neutral PD solution. A reconstituted solution of cefepime was injected into a total of 9 PD bags and stored at 4°C, 25°C or 37°C for various time points. Cefepime retained more than 90% of its initial concentration for 168, 96, and 12 hours at 4°C, 25°C and 37°C, respectively. No apparent physical precipitation or pH change was observed during the study. This study provides crucial information to healthcare professionals on the physical and chemical stability of cefepime in the pH-neutral solution to help them in preparing such admixtures in advance where required.
Copyright © 2016 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Cefepime; compatibility; pH neutral; peritoneal dialysis; peritonitis; stability

Mesh:

Substances:

Year:  2016        PMID: 27385807      PMCID: PMC4934442          DOI: 10.3747/pdi.2015.00169

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  5 in total

1.  Peritoneal dialysis-related infections recommendations: 2010 update.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Judith Bernardini; Ana E Figueiredo; Amit Gupta; David W Johnson; Ed J Kuijper; Wai-Choong Lye; William Salzer; Franz Schaefer; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2010 Jul-Aug       Impact factor: 1.756

Review 2.  Gram-negative peritonitis--the Achilles heel of peritoneal dialysis?

Authors:  Cheuk-Chun Szeto; Kai-Ming Chow
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

Review 3.  Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.

Authors:  Filip de Vin; Peter Rutherford; Dirk Faict
Journal:  Perit Dial Int       Date:  2009 Jan-Feb       Impact factor: 1.756

4.  First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag.

Authors:  C Lage; M Pischetsrieder; C Aufricht; A Jörres; H Schilling; J Passlick-Deetjen
Journal:  Perit Dial Int       Date:  2000       Impact factor: 1.756

5.  Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.

Authors:  Cheuk-Chun Szeto; Kai-Ming Chow; Christopher Wai-Kei Lam; Chi-Bon Leung; Bonnie Ching-Ha Kwan; Kwok-Yi Chung; Man-Ching Law; Philip Kam-Tao Li
Journal:  Nephrol Dial Transplant       Date:  2006-09-27       Impact factor: 5.992

  5 in total
  1 in total

Review 1.  Stability and compatibility of antibiotics in peritoneal dialysis solutions.

Authors:  Simon Wai Yin So; Lu Chen; Alex Yuk Hei Woo; Derek Man Him Ng; Jennifer Ka Wah Wong; Kai Ming Chow; Naomi Runnegar; David W Johnson; Philip Kam-Tao Li
Journal:  Clin Kidney J       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.